Development of an impedance-based fast antimicrobial susceptibility test for Neisseria gonorrhoeae

Article


Daniels, C.N., Martin, B.K., Nahar, K.S., Rahman, K., Sutton, J.M. and Bock, L.J. 2026. Development of an impedance-based fast antimicrobial susceptibility test for Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy. 81 (2). https://doi.org/10.1093/jac/dkaf493
TypeArticle
TitleDevelopment of an impedance-based fast antimicrobial susceptibility test for Neisseria gonorrhoeae
AuthorsDaniels, C.N., Martin, B.K., Nahar, K.S., Rahman, K., Sutton, J.M. and Bock, L.J.
Abstract

Objectives
Antimicrobial-resistant Neisseria gonorrhoeae is a serious threat to global health. Current N. gonorrhoeae antimicrobial susceptibility testing (AST) is laborious and time consuming (≥2 days) leading to overprescription of last-resort, broad-spectrum antibiotics. In this proof-of-principle study, we developed a fast (<8 h) phenotypic, impedance-based AST for N. gonorrhoeae against frontline and experimental antibiotics.

Methods
WHO N. gonorrhoeae reference strains F, K, O, V, X and Y were exposed to EUCAST susceptibility breakpoint concentrations of ceftriaxone, ciprofloxacin and azithromycin for up to 5 h and to doubling dilutions of antibiotics for 4 h. The % cell count of antibiotic exposed compared with unexposed control samples, as measured by an impedance-based Fast Antimicrobial Susceptibility Test (iFAST®), was used to differentiate between susceptible and non-susceptible strains. Responses to novel antimicrobial compounds, including zoliflodacin and gepotidacin, were also measured by iFAST® and compared with published MICs.

Results
The protocol reported susceptibility profiles concordant with published data for all strain-drug combinations after 4 h of exposure. Dose–response curves generated using iFAST® for most strain-drug combinations were in essential agreement with published Etest MIC values. Novel compounds assessed using iFAST® showed higher antimicrobial activity than ciprofloxacin in the high-level resistant strain WHO X.

Conclusions
iFAST® AST results were concordant with the current clinical standards and measured in under 8 h. This method is therefore promising for the development of a rapid and accurate phenotypic N. gonorrhoeae antimicrobial susceptibility test.

Sustainable Development Goals3 Good health and well-being
Middlesex University ThemeHealth & Wellbeing
PublisherOxford University Press (OUP)
JournalJournal of Antimicrobial Chemotherapy
ISSN0305-7453
Electronic1460-2091
Publication dates
Online28 Jan 2026
PrintFeb 2026
Publication process dates
Submitted04 Jun 2025
Accepted17 Dec 2025
Deposited16 Mar 2026
Output statusPublished
Accepted author manuscript
License
File Access Level
Open
Copyright Statement

This is a pre-copyedited, author-produced version of an article accepted for publication in Journal of International Criminal Justice following peer review. The version of record: Caitlin N Daniels, Bethany K Martin, Kazi S Nahar, Khondaker Miraz Rahman, J Mark Sutton, Lucy J Bock, Development of an impedance-based fast antimicrobial susceptibility test for Neisseria gonorrhoeae, Journal of Antimicrobial Chemotherapy, Volume 81, Issue 2, February 2026, dkaf493, https://doi.org/10.1093/jac/dkaf493

Digital Object Identifier (DOI)https://doi.org/10.1093/jac/dkaf493
PubMed ID41603568
Permalink -

https://repository.mdx.ac.uk/item/350178

Download files


Accepted author manuscript
  • 17
    total views
  • 6
    total downloads
  • 1
    views this month
  • 0
    downloads this month

Export as

Related outputs

Design, synthesis, and biological evaluation of azole antifungals against multidrug-resistant Candida auris
Chen, Y., Li, Y., Nahar, K.S., Hind, C.K., Sutton, M. and Rahman, K.M. 2026. Design, synthesis, and biological evaluation of azole antifungals against multidrug-resistant Candida auris. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00330c
Designing antibiotics with inherent resistance to efflux as a strategy to revive discovery against multidrug resistant pathogens
Laws, M., Hind, C.K., Nahar, K., Clifford, M., Marsh, C., al Adhami, T., Louis, B., Xu, M., Alyemni, S.O., Haider, S., Hassan, M., Gargate, N., Wand, M.E., Sutton, J.M. and Rahman, K.M. 2026. Designing antibiotics with inherent resistance to efflux as a strategy to revive discovery against multidrug resistant pathogens. Journal of Medicinal Chemistry. 69 (11), pp. 13071-13098. https://doi.org/10.1021/acs.jmedchem.6c00060
Efflux resistance breakers: a new technology to overcome efflux-mediated resistance in multidrug resistant bacteria
Laws, M., Hind, C., Nahar, K., Clifford, M., Marsh, C., Xu, M., Alyemni, S., Haider, S., Hassan, M., Gargate, N., Wand, M., Sutton, M. and Rahman, K.M. 2025. Efflux resistance breakers: a new technology to overcome efflux-mediated resistance in multidrug resistant bacteria. https://doi.org/10.26434/chemrxiv-2025-gsw00
Convergent evolution of antibiotic resistance mechanisms between pyrrolobenzodiazepines and albicidin in multidrug resistant Klebsiella pneumoniae
Surani, Y.M., Wand, M.E., Picconi, P., Di Palma, M., Zenezini Chiozzi, R., Hasan, Md. M., Andriollo, P., Grätz, S., Nahar, K., Maynard-Smith, M., Süssmuth, R.D., Steiner, R.A., Rahman, K.M., Hind, C.K and Sutton, J. M. 2025. Convergent evolution of antibiotic resistance mechanisms between pyrrolobenzodiazepines and albicidin in multidrug resistant Klebsiella pneumoniae. npj Antimicrobials and Resistance . 3 (1). https://doi.org/10.1038/s44259-025-00104-4
New generation modified azole antifungals against multidrug-resistant Candida auris
Chen, Y., Li, Y., Nahar, K., Hasan, Md. M., Marsh, C., Clifford, M., Aleku, G.A., Kelly, S.L., Lamb, D.C., Mpamhanga, C.D., Kounatidis, I., Shah, A., Hind, C.K., Sutton, J.M. and Rahman, K.M. 2025. New generation modified azole antifungals against multidrug-resistant Candida auris . Journal of Medicinal Chemistry. 68 (13), pp. 14054-14071. https://doi.org/10.1021/acs.jmedchem.5c01253
Evaluation of antibiotic resistance mechanisms in gram-positive bacteria
Rajput, P., Nahar, K.S. and Rahman, K. 2024. Evaluation of antibiotic resistance mechanisms in gram-positive bacteria. Antibiotics. 13 (12). https://doi.org/10.3390/antibiotics13121197
Mechanistic insight into the repair of C8-linked pyrrolobenzodiazepine monomer-mediated DNA damage
Joseph, A.M., Nahar, K., Daw, S., Hasan, M.M., Lo, R., Le, T.B.K., Rahman, K.M. and Badrinarayanan, A. 2022. Mechanistic insight into the repair of C8-linked pyrrolobenzodiazepine monomer-mediated DNA damage. RSC Medicinal Chemistry. 13 (12), pp. 1621-1633. https://doi.org/10.1039/d2md00194b
Current trends and future approaches in small-molecule therapeutics for COVID-19
Laws, M., Surani, Y.M., Hasan, M.M., Chen, Y., Jin, P., Al-Adhami, T., Chowdhury, M., Imran, A., Psaltis, I., Jamshidi, S., Nahar, K.S. and Rahman, K.M. 2021. Current trends and future approaches in small-molecule therapeutics for COVID-19. Current Medicinal Chemistry. 28 (19), pp. 3803-3824. https://doi.org/10.2174/0929867327666200721161840